- Home
- FBRT vs CRMD Comparison
FBRT vs CRMD Comparison
Compare FBRT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRT | CRMD |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 882.8M | 958.1M |
| IPO Year | 1985 | 2010 |
Fundamental Metrics
Financial Performance| Metric | FBRT | CRMD |
|---|---|---|
| Price | $10.32 | $6.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $14.33 | ★ $17.29 |
| AVG Volume (30 Days) | 766.7K | ★ 4.1M |
| Earning Date | 02-11-2026 | 11-12-2025 |
| Dividend Yield | ★ 13.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.80 | ★ 2.25 |
| Revenue | ★ $241,051,000.00 | $214,303,672.00 |
| Revenue This Year | $28.41 | $628.67 |
| Revenue Next Year | $58.29 | $14.64 |
| P/E Ratio | $12.88 | ★ $3.01 |
| Revenue Growth | 32.77 | ★ 1647.67 |
| 52 Week Low | $9.65 | $5.60 |
| 52 Week High | $13.58 | $17.43 |
Technical Indicators
Market Signals| Indicator | FBRT | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.64 | 22.73 |
| Support Level | $9.83 | $7.01 |
| Resistance Level | $10.37 | $7.44 |
| Average True Range (ATR) | 0.22 | 0.66 |
| MACD | 0.02 | -0.53 |
| Stochastic Oscillator | 80.09 | 0.40 |
Price Performance
Historical ComparisonAbout FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.